Revance Therapeutics Inc. (RVNC)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
D E ShawNOTE

D. E. Shaw

38,122,000 $28,124,491 0.02%
2.
Palo Alto Investors

William Leland Edwards

5,248,004 $25,820,180 +1% 2.91%
3.
Graham Capital ManagementNOTE 1.750% 2/1

Kenneth Tropin

31,929,000 $23,497,748 0.44%
4.
Polar Capital

Brian Ashford-Russell And Tim Woolley

3,884,819 $19,113,309 +23% 0.1%
5. 2,656,847 $13,071,687 +82% 0.38%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.98 30,000 Officer, Director 1,015,468 2024-03-06 Filing
$15.74 6,400 Director 26,913 2021-12-13 Filing
$14.43 30,000 Officer, Director 95,463 2021-12-03 Filing
$12.90 40,000 Officer, Director 110,913 2021-11-29 Filing
$31.20 900 Director 6,150 2018-03-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.80 2,392 Officer 114,864 2024-04-16 Filing
$5.04 9,211 Officer 167,550 2024-03-18 Filing
$5.04 8,125 Officer 137,815 2024-03-18 Filing
$5.04 9,361 Officer 192,666 2024-03-18 Filing
$17.06 11,000 Officer 44,066 2023-09-06 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 11,939,076 $104,944,478 0.01%
2. 7,453,371 $65,515,131 0%
3. 5,069,625 $44,562,004 0%
4. 4,749,539 $41,748,450 0.01%
5. 4,643,419 $40,815,652 0%
News See All